AGP
GILD icon

Autumn Glory Partners’s Gilead Sciences GILD Stock Holding History

Autumn Glory Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$265K Hold
2,099
– – 0.08% 186
2026
Q1 		$293K Hold
2,099
– – 0.11% 169
2025
Q4 		$258K Buy
+2,099
New +$255K 0.09% 179

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Autumn Glory Partners's GILD Position: Q2 2026 in Review

Autumn Glory Partners held its Gilead Sciences (GILD) position steady in Q2 2026 at 2,099 shares worth $265K. The position accounts for 0.08% of the portfolio, ranked #186.

Autumn Glory Partners first reported a position in GILD in Q4 2025 and has held it in 3 quarters since. The position peaked at $293K in Q1 2026. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Autumn Glory Partners held 2,099 shares of Gilead Sciences worth $265K as of Q2 2026.
  • Autumn Glory Partners left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.08% of Autumn Glory Partners's portfolio in Q2 2026, its #186 holding.
  • Autumn Glory Partners first reported a position in Gilead Sciences in Q4 2025 and has held it in 3 quarters since.
  • Autumn Glory Partners's Gilead Sciences position peaked at $293K in Q1 2026.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Autumn Glory Partners's 13F filing for Q2 2026, filed 3 Aug 2026.